$AGN Allergan plc Insider Trading Week 18/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan plc in week 18/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2017 | AGN | Allergan plc | GALLAGHER MICHAEL R | Director | Option Exercise | M | 245.25 | 17,693 | 4,339,208 | 0 | |
| May 05 2017 | AGN | Allergan plc | GALLAGHER MICHAEL R | Director | Buy | M | 245.25 | 17,693 | 4,339,208 | 20,272 | 2.6 K to 20.3 K (+686.04 %) |
| May 05 2017 | AGN | Allergan plc | GALLAGHER MICHAEL R | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 2,579 | 3.2 K to 2.6 K (-20.57 %) |
| May 05 2017 | AGN | Allergan plc | KLEMA CATHY | Director | Grant | A | 245.25 | 1,223 | 299,941 | 23,639 | 22.4 K to 23.6 K (+5.46 %) |
| May 05 2017 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 245.25 | 1,223 | 299,941 | 4,446 | 3.2 K to 4.4 K (+37.95 %) |
| May 05 2017 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 3,223 | 3.9 K to 3.2 K (-17.17 %) |
| May 05 2017 | AGN | Allergan plc | McDonnell Peter J | Director | Grant | A | 245.25 | 1,223 | 299,941 | 4,835 | 3.6 K to 4.8 K (+33.86 %) |
| May 05 2017 | AGN | Allergan plc | McDonnell Peter J | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 3,612 | 4.3 K to 3.6 K (-15.61 %) |
| May 05 2017 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 245.25 | 1,223 | 299,941 | 27,690 | 26.5 K to 27.7 K (+4.62 %) |
| May 05 2017 | AGN | Allergan plc | WEISS FRED G | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 26,467 | 27.1 K to 26.5 K (-2.46 %) |
| May 05 2017 | AGN | Allergan plc | BLOEM JAMES H | Director | Grant | A | 245.25 | 1,223 | 299,941 | 11,163 | 9.9 K to 11.2 K (+12.30 %) |
| May 05 2017 | AGN | Allergan plc | BLOEM JAMES H | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 9,940 | 10.6 K to 9.9 K (-6.30 %) |
| May 05 2017 | AGN | Allergan plc | Brown Adriane M | Director | Grant | A | 245.25 | 1,223 | 299,941 | 1,399 | 176 to 1.4 K (+694.89 %) |
| May 05 2017 | AGN | Allergan plc | Brown Adriane M | Director | Payment of Exercise | F | 243.76 | 163 | 39,733 | 176 | 339 to 176 (-48.08 %) |
| May 05 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 245.25 | 1,223 | 299,941 | 6,030 | 4.8 K to 6 K (+25.44 %) |
| May 05 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 4,807 | 5.5 K to 4.8 K (-12.20 %) |
| May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 245.25 | 1,223 | 299,941 | 234,047 | 232.8 K to 234 K (+0.53 %) |
| May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 243.76 | 214 | 52,165 | 232,824 | 233 K to 232.8 K (-0.09 %) |
| May 05 2017 | AGN | Allergan plc | TAYLOR RONALD R | Director | Grant | A | 245.25 | 1,223 | 299,941 | 25,305 | 24.1 K to 25.3 K (+5.08 %) |
| May 05 2017 | AGN | Allergan plc | TAYLOR RONALD R | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 24,082 | 24.8 K to 24.1 K (-2.70 %) |
| May 05 2017 | AGN | Allergan plc | O'Sullivan Patrick J | Director | Grant | A | 245.25 | 1,223 | 299,941 | 5,236 | 4 K to 5.2 K (+30.48 %) |
| May 05 2017 | AGN | Allergan plc | O'Sullivan Patrick J | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 4,013 | 4.7 K to 4 K (-14.27 %) |
| May 05 2017 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 245.25 | 1,223 | 299,941 | 14,068 | 12.8 K to 14.1 K (+9.52 %) |
| May 05 2017 | AGN | Allergan plc | BODINE CHRIS W | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 12,845 | 13.5 K to 12.8 K (-4.94 %) |